This inventor holds 1 USPTO granted patent and 6 EPO patents. Top assignees: Advaxis, Inc., University of Pennsylvania. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 20 
1 out of 2,655 
Years Active: 2016
Title: **Inventor Profile: Paulo MaCiag**
Introduction
Paulo MaCiag is a notable inventor based in Long Grove, Illinois. He holds a significant patent that contributes to the field of immunology and vaccine development. With a strong background in biomedical research, he has worked in prominent organizations that have propelled his innovations.
Latest Patents
MaCiag is credited with a patent titled "Non-hemolytic LLO fusion proteins and methods of utilizing same." This invention involves recombinant proteins or peptides that include a mutated listeriolysin O (LLO) protein or its fragments. The patented technology focuses on modifications to the cholesterol-binding domain, which has applications in creating vaccine vectors. The methods developed from this patent aim to induce an immune response to specific peptides, showcasing its potential for therapeutic advancements in vaccines.
Career Highlights
Throughout his career, Paulo MaCiag has been associated with esteemed institutions. He has contributed significantly to Advaxis, Inc., a biotechnology company specializing in innovative cancer immunotherapies. Additionally, he has collaborated with the University of Pennsylvania, where he honed his research skills and contributed to groundbreaking science in vaccine development. His work in these institutions emphasizes his commitment to advancing healthcare through innovation.
Collaborations
Working alongside renowned professionals, MaCiag's collaboration with Yvonne Paterson has been pivotal in his projects. This partnership highlights the importance of teamwork in scientific research and development, fostering an environment for innovative breakthroughs in immunology.
Conclusion
Paulo MaCiag's contributions to the field of biotechnology through his patented inventions and collaborative efforts underline the critical role of innovation in healthcare. His work on non-hemolytic LLO fusion proteins paves the way for advancements in vaccine technology, making a meaningful impact on disease prevention strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile